Allarity Therapeutics, Inc. (ALLR) stock
Close on Nov 17, 2026Market cap $13.38MP/E –Yield –
Earnings
Allarity Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Allarity Therapeutics's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | Aug 14, 2026after the close | – | – | -$0.21 | Release |
| Q1 FY2026ended Mar 31, 2026 | Apr 1, 2026before the open | $320.00K | – | – | Release |
| Q1 FY2025ended Mar 31, 2025 | May 9, 2025after the close | – | – | – | Release |
| Q4 FY2024ended Dec 31, 2024 | Mar 31, 2025after the close | – | – | – | Release |
| Q3 FY2024ended Sep 30, 2024 | Nov 14, 2024before the open | – | – | -$7.71 | Release |
| Q1 FY2024ended Mar 31, 2024 | May 15, 2024before the open | – | – | -$22.14 | Release |
| Q4 FY2023ended Dec 31, 2023 | Mar 8, 2024before the open | – | – | – | Release |
| Q3 FY2022ended Sep 30, 2022 | Nov 15, 2022after the close | – | – | -$0.68 | Release |
| Q2 FY2022ended Jun 30, 2022 | Aug 22, 2022after the close | – | – | – | Filing |
| Q1 FY2022ended Mar 31, 2022 | May 17, 2022after the close | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Guidance
Allarity Therapeutics has not given guidance in its releases
Many companies give their outlook only on the conference call or not at all. When Allarity Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.
Press releases
Releases Allarity Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K
- News
- News
- News
- News
- News
- News
- Results
- News
- News
- Update
- Update
- News
- News
- News
- Results
See a number that looks wrong?